Improved donor/acceptor BRET couples for monitoring β‐arrestin recruitment to G protein‐coupled receptors

We report highly sensitive bioluminescence resonance energy transfer (BRET) assays with optimized donor/acceptor couples. We combined the energy donors Renilla luciferase (Rluc) and the Rluc8 variant with the energy acceptors yellow fluorescent protein, the YPet variant and the Renilla green fluorescent protein (RGFP). Different donor/acceptor couples were tested in well‐established assays measuring ligand‐induced β‐arrestin (βARR) intramolecular rearrangements and recruitment to G protein‐coupled receptors. We show increased sensitivity with Rluc8/YPet and Rluc8/RGFP couples and measured previously undetectable BRET signals. These tools improve existing βARR assays and offer new options for the development of future BRET assays.

[1]  K. Eidne,et al.  Demonstration of Improvements to the Bioluminescence Resonance Energy Transfer (BRET) Technology for the Monitoring of G Protein–Coupled Receptors in Live Cells , 2008, Journal of biomolecular screening.

[2]  Arun K Shukla,et al.  Distinct conformational changes in β-arrestin report biased agonism at seven-transmembrane receptors , 2008, Proceedings of the National Academy of Sciences.

[3]  Cyril Couturier,et al.  The BRET technology and its application to screening assays , 2008, Biotechnology journal.

[4]  W. Blankesteijn,et al.  G protein-independent cell-based assays for drug discovery on seven-transmembrane receptors. , 2008, Biotechnology annual review.

[5]  P. Molinari,et al.  Functional complementation of high-efficiency resonance energy transfer: a new tool for the study of protein binding interactions in living cells. , 2008, The Biochemical journal.

[6]  S. Gambhir,et al.  An improved bioluminescence resonance energy transfer strategy for imaging intracellular events in single cells and living subjects. , 2007, Cancer research.

[7]  R. Eglen,et al.  Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. , 2007, Assay and drug development technologies.

[8]  Sanjiv Sam Gambhir,et al.  Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output. , 2006, Protein engineering, design & selection : PEDS.

[9]  Philippe Delagrange,et al.  The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization , 2006, The EMBO journal.

[10]  K. Eidne,et al.  Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET) , 2006, Nature Methods.

[11]  Christine C. Hudson,et al.  The ligand-independent translocation assay: an enabling technology for screening orphan G protein-coupled receptors by arrestin recruitment. , 2006, Methods in enzymology.

[12]  J. Pelletier,et al.  High-Throughput Screening of G Protein-Coupled Receptor Antagonists Using a Bioluminescence Resonance Energy Transfer 1-Based β-Arrestin2 Recruitment Assay , 2005, Journal of biomolecular screening.

[13]  Michel Bouvier,et al.  Methods to monitor the quaternary structure of G protein‐coupled receptors , 2005, The FEBS journal.

[14]  Pascale G. Charest,et al.  Monitoring agonist‐promoted conformational changes of β‐arrestin in living cells by intramolecular BRET , 2005, EMBO reports.

[15]  Patrick S Daugherty,et al.  Evolutionary optimization of fluorescent proteins for intracellular FRET , 2005, Nature Biotechnology.

[16]  P. Delagrange,et al.  Preferential Formation of MT1/MT2 Melatonin Receptor Heterodimers with Distinct Ligand Interaction Properties Compared with MT2 Homodimers , 2004, Molecular Pharmacology.

[17]  M. Caron,et al.  Green fluorescent protein-tagged beta-arrestin translocation as a measure of G protein-coupled receptor activation. , 2004, Methods in molecular biology.

[18]  R. Jockers,et al.  Activation of the Leptin Receptor by a Ligand-induced Conformational Change of Constitutive Receptor Dimers* , 2003, Journal of Biological Chemistry.

[19]  Jean-François Mercier,et al.  Quantitative Assessment of β1- and β2-Adrenergic Receptor Homo- and Heterodimerization by Bioluminescence Resonance Energy Transfer* , 2002, The Journal of Biological Chemistry.

[20]  Graeme Milligan,et al.  Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences. , 2002, The Biochemical journal.

[21]  P. Fossier,et al.  Monitoring of Ligand-independent Dimerization and Ligand-induced Conformational Changes of Melatonin Receptors in Living Cells by Bioluminescence Resonance Energy Transfer* 210 , 2002, The Journal of Biological Chemistry.

[22]  R. Lefkowitz,et al.  The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. , 2002, Journal of cell science.

[23]  S. Angers,et al.  THE BRET2/ARRESTIN ASSAY IN STABLE RECOMBINANT CELLS: A PLATFORM TO SCREEN FOR COMPOUNDS THAT INTERACT WITH G PROTEIN-COUPLED RECEPTORS (GPCRS)* , 2002, Journal of receptor and signal transduction research.

[24]  Jean-François Mercier,et al.  Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. , 2002, The Journal of biological chemistry.

[25]  A. Hanyaloglu,et al.  Constitutive and Agonist-dependent Homo-oligomerization of the Thyrotropin-releasing Hormone Receptor , 2001, The Journal of Biological Chemistry.

[26]  S. Angers,et al.  Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Johnson,et al.  A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.